e-learning
resources
ERJ
2006
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Autoimmune polyglandular syndrome and pulmonary arterial hypertension
Garcia-Hernandez F. J., Ocana-Medina C., Gonzalez-Leon R., Garrido-Rasco R., Sanchez-Roman J.
Source:
Eur Respir J 2006; 27: 657
Journal Issue:
March
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Garcia-Hernandez F. J., Ocana-Medina C., Gonzalez-Leon R., Garrido-Rasco R., Sanchez-Roman J.. Autoimmune polyglandular syndrome and pulmonary arterial hypertension. Eur Respir J 2006; 27: 657
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
The metabolic syndrome and pulmonary hypertension
Source: Virtual Congress 2020 – Pulmonary vascular diseases
Year: 2020
Pulmonary arterial hypertension: an autoimmune disease?
Source: Eur Respir J 2005; 26: 986-988
Year: 2005
Pulmonary hypertension in hypoventilation syndromes
Source: Eur Respir J 2014; 43: 12-15
Year: 2004
Pulmonary arterial hypertension associated with congenital heart disease
Source: Eur Respir Rev 2012 21: 328-337
Year: 2012
Prevalence of hyperventilation syndrome in pulmonary arterial hypertension
Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Year: 2020
Pulmonary arterial hypertension in a patient with stage II sarcoidosis and Hashitoxicosis
Source: Eur Respir Rev 2009; 18: 125-128
Year: 2009
Pulmonary arterial hypertension in systemic sclerosis: a distinctive endotheliopathy?
Source: Eur Respir J 2010; 35: 223-224
Year: 2010
Charactaristics and prognosis of autoimmune antibody-positive patients of idiopathic pulmonary arterial hypertension
Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond
Year: 2021
TBX4 syndrome: a systemic disease highlighted by pulmonary arterial hypertension in its most severe form
Source: Eur Respir J, 55 (5) 2000585; 10.1183/13993003.00585-2020
Year: 2020
Pulmonary hypertension in patients with chronic myeloproliferative disorders
Source: Eur Respir J 2010; 35: 1396-1406
Year: 2010
Pulmonary veno-occlusive disease misdiagnosed as idiopathic pulmonary arterial hypertension
Source: Eur Respir Rev 2009; 18: 177-180
Year: 2009
An autopsy case of portopulmonary hypertension associated with idiopathic portal hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013
Portopulmonary hypertension and hepatopulmonary syndrome: a clinician-oriented overview
Source: Eur Respir Rev 2012 21:223-233
Year: 2012
Hepatopulmonary syndrome following portopulmonary hypertension
Source: Eur Respir J 2007; 29: 1277-1280
Year: 2007
Pulmonary hypertension in children
Source: Eur Respir Mon 2012; 57: 94-107
Year: 2012
Portopulmonary hypertension: a further clue to pathogenesis?
Source: Annual Congress 2005 - Challenges in the biological understanding of pulmonary arterial hypertension
Year: 2005
Pulmonary hypertension in systemic scleroderma
Source: Eur Respir J 2003; 22: Suppl. 45, 269s
Year: 2003
Pulmonary arterial hypertension in scleroderma – manifestation of systemic endothelial dysfunction
Source: Eur Respir J 2006; 28: Suppl. 50, 548s
Year: 2006
Pulmonary arterial hypertension masquerading as severe refractory asthma
Source: Eur Respir J 2008; 32: 513-516
Year: 2008
Fatal primary pulmonary hypertension in a 30-yr-old female with APECED syndrome
Source: Eur Respir J 2003 Oct 01;22(4):709-711
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept